Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-04-26 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +417 6,537
2020-04-26 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −417 2,917
2020-04-26 Mullennix Stephen Chief Operating Officer Exercise or conversion +417 10,229
2020-04-26 Mullennix Stephen Chief Operating Officer Exercise or conversion · Restricted Stock Units (RSUs) −417 2,917
2020-04-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 148,657
2020-04-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 198,956
2020-03-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,042 17,918
2020-03-04 Schoenberg Mark Chief Medical Officer Shares withheld for taxes −345 $29.50 $10K 17,573
2020-03-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −1,042 3,125
2020-03-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 139,850
2020-03-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 193,763
2020-02-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +1,042 6,480
2020-02-20 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −360 $29.68 $11K 6,120
2020-02-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,042 6,249
2020-02-14 Mullennix Stephen Chief Operating Officer Exercise or conversion +1,759 10,424
2020-02-14 Mullennix Stephen Chief Operating Officer Sale −612 $28.04 $17K 9,812
2020-02-14 Mullennix Stephen Chief Operating Officer Exercise or conversion · Restricted Stock Units −1,759 7,037
2020-02-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 131,043
2020-02-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 202,570
2020-01-31 PFREUNDSCHUH PETER P. Chief Financial Officer Grant or award · Stock options (right to buy) +15,000 15,000

Page 22 of 25 · 496 trades